Duhaylungsod, Charlene T.

HRN: 20-15-39  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2022
CEFUROXIME 1.5GM (VIAL)
04/30/2022
04/30/2022
IVT
1.5g
Loading Dose
G1P0 39 2/7 Weeks AOG, Breech In Labor; For Stat 1° CS Due To Breech
Waiting Final Action 
04/30/2022
CEFUROXIME 750MG (VIAL)
04/30/2022
05/01/2022
IVT
750mg
Q8H
S/P 1° CS Due To Breech
05/01/2022
CEFUROXIME 500MG (TAB)
05/01/2022
05/07/2022
PO
500mg
BID
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: